Healthcare & Life Sciences
Ditto Biosciences
United States
series-a
series-a
Stage
1
Investors
About
Ditto Biosciences uses artificial intelligence to identify parasite-derived proteins that modulate the human immune system and engineers them into potential therapies for autoimmune diseases.
Explore Ditto Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.